• Nayelli C Flores-García, Mae Dirac, Hannah Han, and David Kershenobich-Stalnikowitz.
• Department of Gastroenterology and Department of Hepatology and Liver Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.
• Gac Med Mex. 2023 Jan 1; 159 (6): 494501494-501.

BackgroundLiver cirrhosis is a major cause of morbidity and mortality worldwide. In Mexico, it is one of the six leading causes of death.ObjectiveTo analyze epidemiological data derived from the Global Burden of Disease study and their relationship with risk factors associated with the development of chronic liver diseases in Mexico.Material And MethodsAn analysis of data from the Institute for Health Metrics and Evaluation and the National Institute of Geography and Statistics was carried out.ResultsLiver cirrhosis has a high prevalence in Mexico, with significant burden of disease translating into lost years of healthy life, premature death and disability. Mortality due to cirrhosis ranked sixth (3.6%) in 2021 and was the eighth cause of years of healthy life lost (2.8%). From 1990 to 2021, the mortality rate increased from 26.7 to 34.2 per 100,000 population.ConclusionsThe burden of disease due to liver cirrhosis continues to be caused by alcohol consumption and hepatitis C; cirrhosis caused by steatotic liver disease has increased in terms of prevalence over the past decade. There are epidemiological changes in the frequency and burden of chronic liver disease that show territorial variations in Mexico.Copyright: © 2023 Permanyer.

16 keywords...

hide…